Phase 3 HIV and AIDS Trial, Recruiting (NCT06919614)

Phase 3 HIV and AIDS Trial, Recruiting NCT06919614 Sponsor: Botswana Harvard AIDS Institute Partnership Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT06919614 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are pregnant and attending antenatal (pregnancy) care appointments
People who identify as a cisgender woman
People who do not have HIV
People who are not currently taking PrEP (a medication used to prevent HIV)
People who are planning to stay in the same city or town where they enrol until 9 months after giving birth
People who are planning to receive both pregnancy and postnatal care in the same city or town where they enrol
People who are willing and able to give informed consent to participate in the trial

Who may not be able to join:

People who identify as male
People who are not currently pregnant
People who are living with HIV
People who are currently taking PrEP
People who do not plan to remain in the enrolment city or town until 9 months after delivery
People who do not plan to receive pregnancy and postnatal care in the enrolment city or town
People who are not able or willing to give informed consent for participation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: ‭+267 316 6657‬

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06919614

Sponsor: Botswana Harvard AIDS Institute Partnership

Phase: Phase 3

Status: Recruiting

Condition: HIV and AIDS

Trial contact: ‭+267 316 6657‬

More information: https://clinicaltrials.gov/study/NCT06919614

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are pregnant and attending antenatal (pregnancy) care appointments
People who identify as a cisgender woman
People who do not have HIV
People who are not currently taking PrEP (a medication used to prevent HIV)
People who are planning to stay in the same city or town where they enrol until 9 months after giving birth
People who are planning to receive both pregnancy and postnatal care in the same city or town where they enrol
People who are willing and able to give informed consent to participate in the trial

Who may not be able to join:

People who identify as male
People who are not currently pregnant
People who are living with HIV
People who are currently taking PrEP
People who do not plan to remain in the enrolment city or town until 9 months after delivery
People who do not plan to receive pregnancy and postnatal care in the enrolment city or town
People who are not able or willing to give informed consent for participation

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 3

Sponsor

Botswana Harvard AIDS Institute Partnership

Registry

ClinicalTrials.gov

Start date

18 June 2025

Est. completion

31 August 2027

Where this trial is recruiting

Botswana

Primary endpoints

PrEP initiation among pregnant women seeking antenatal care; PrEP persistence; PrEP adherence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov